Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY

v3.24.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
BALANCE BEGINNING at Dec. 31, 2021 $ 1,382,023 $ 61 $ 182,560,859 $ (150,897,789) $ 33,045,154
BALANCE BEGINNING (in shares) at Dec. 31, 2021 111.11 6,110,125      
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs   $ 33 9,610,622   9,610,655
Issuance of common stock, pre-funded warrants and warrants, net of issuance costs (in shares)   3,275,153      
Stock-based compensation     1,452,964   $ 1,452,964
Retired Shares (in shares)   (6)      
Stock awards (in shares)         440,250
Net loss       (28,601,254) $ (28,601,254)
BALANCE ENDING at Dec. 31, 2022 $ 1,382,023 $ 94 193,624,445 (179,499,043) 15,507,519
BALANCE ENDING (in shares) at Dec. 31, 2022 111.11 9,385,272      
Stock-based compensation     2,410,288   2,410,288
Exercise of warrants into common shares   $ 12 789,630   789,642
Exercise of warrants into common shares (in shares)   1,197,622      
Issuance of preferred stock, net of issuance costs $ 17,920,000       17,920,000
Issuance of preferred stock, net of issuance costs (in shares) 1,225.00        
Conversion of preferred stock to common stock $ (13,242,368) $ 99 13,242,269   $ 13,242,368
Conversion of preferred stock to common stock(in shares) (905.24) 9,947,684      
Stock awards   $ 2 (2)    
Stock awards (in shares)   213,532     1,617,000
Net loss       (37,983,496) $ (37,983,496)
BALANCE ENDING at Dec. 31, 2023 $ 6,059,655 $ 207 $ 210,066,630 $ (217,482,539) $ (1,356,047)
BALANCE ENDING (in shares) at Dec. 31, 2023 430.87 20,744,110      
Conversion of pre-funded warrants into common shares (in shares) (905.24) 9,947,684